BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 6441295)

  • 1. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 2. Nursing assessment of symptoms associated with hyperviscosity syndrome.
    Trotta P; Knobf MT
    Oncol Nurs Forum; 1987; 14(1):21-5. PubMed ID: 3101042
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperviscosity and disease].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Mar; 125(12):80, 82, 84. PubMed ID: 6406848
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperviscosity syndrome (author's transl)].
    Yoshinaga K; Onodera K
    Kokyu To Junkan; 1978 Nov; 26(11):1059-63. PubMed ID: 103156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperviscosity syndrome in plasma cell dyscrasias].
    Somer T
    Duodecim; 1977; 93(9):586-603. PubMed ID: 406132
    [No Abstract]   [Full Text] [Related]  

  • 10. [Macroglobulinemia Waldenstrom with hyperviscosity syndrome].
    Bauer KH
    Med Welt; 1975 Feb; 26(8):341-8. PubMed ID: 803607
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma viscosity changes after sham plasmapheresis.
    Jakoet A; Martell RW; Jacobs P
    Lancet; 1987 Oct; 2(8566):1031-2. PubMed ID: 2889944
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].
    Di Lollo F; Fazzini G; Avanzi G
    Ric Clin Lab; 1983; 13 Suppl 3():225-44. PubMed ID: 6424221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reestablishment of plasma proteins after plasmapheresis in patients with paraproteinemic hemoblastosis].
    Movshev BE; Kalinin NN; Petrov MM; Petrova VI
    Ter Arkh; 1999; 71(10):40-3. PubMed ID: 10612173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of blood hyperviscosity syndrome with continuous plasma exchange using a Fenval CS 3000 separator in patients with multiple myeloma].
    Usnarska-Zubkiewicz L; Gola A
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):123-5. PubMed ID: 8361907
    [No Abstract]   [Full Text] [Related]  

  • 16. Anemia, splenomegaly and hyperviscosity syndrome.
    Pruzanski W; Chu R; Damji NF; Galler S; Norman CS
    Can Med Assoc J; 1980 Oct; 123(8):731-7. PubMed ID: 6778602
    [No Abstract]   [Full Text] [Related]  

  • 17. CD3+ T lymphocytes and interleukin 2 in myelomatous blood hyperviscosity syndrome treated with plasmapheresis.
    Usnarska-Zubkiewicz L
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):317-22. PubMed ID: 9832072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myeloma serum hyperviscosity syndrome treated with plasmapheresis].
    Radović M; Durić D; Trajković B; Radojicić B; Pekic B; Tomasević R; Dujić A
    Med Pregl; 1977; 30(9-10):471-6. PubMed ID: 600211
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperviscosity syndromes associated with immunoglobulin abnormalities.
    Bloch KJ; Maki DG
    Semin Hematol; 1973 Apr; 10(2):113-24. PubMed ID: 4633222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of plasmapheresis in surgical hematology].
    Abdulkadyrov KM; Shatrov VA; Katsadze IuL
    Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.